[{"NetIncomeLoss_1_Q2_USD":-38607000.0,"RoyaltyExpense_1_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":3000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":22873000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":5792000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":92848000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":575000.0,"AssetsCurrent_0_Q2_USD":203837000.0,"OperatingLeaseExpense_2_Q2_USD":935000.0,"LongTermDebt_0_Q2_USD":50000000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":15438000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":29748000.0,"RoyaltyExpense_2_Q2_USD":69000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":13883000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":0.0,"CostOfGoodsAndServicesSold_1_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":12963000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":14007.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":532000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":665000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q2_USD":14817000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":21417000.0,"CommonStockSharesIssued_0_Q2_shares":176429000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":3510000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":15935000.0,"Assets_0_Q2_USD":214706000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":3834000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":24843000.0,"InterestAndOtherIncome_1_Q2_USD":2758000.0,"InterestAndOtherIncome_2_Q2_USD":9204000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_1_Q2_USD":63000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":835000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":57365000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":27498000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":11295000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":157862000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":161569000.0,"AccountsReceivableNetCurrent_0_Q2_USD":3997000.0,"CommonStockValue_0_Q2_USD":1764000.0,"InterestPayableCurrent_0_Q2_USD":17806000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":401000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":108463000.0,"CostsAndExpenses_2_Q2_USD":87182000.0,"CostsAndExpenses_1_Q2_USD":41381000.0,"StockIssuedDuringPeriodSharesNewIssues_1_Q2_shares":22044000.0,"IncreaseDecreaseInInventories_2_Q2_USD":5233000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-76242000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-38618000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1156000.0,"OtherAssetsNoncurrent_0_Q2_USD":3720000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":173468000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-36000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-11000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-18149000.0,"LineOfCredit_0_Q2_USD":31715000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-11000.0,"ShareBasedCompensation_2_Q2_USD":6034000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":3000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3280000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_2_Q2_USD":1000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-54322000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1723000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":187000.0,"IncreaseDecreaseInDerivativeAssets_2_Q2_USD":-590000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":749000.0,"LiabilitiesCurrent_0_Q2_USD":102650000.0,"DeferredRevenueCurrent_0_Q2_USD":715000.0,"AccountsPayableCurrent_0_Q2_USD":9354000.0,"InterestExpense_2_Q2_USD":5965000.0,"InterestExpense_1_Q2_USD":2918000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3016000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":798000.0,"InterestExpenseDebt_2_Q2_USD":5965000.0,"InterestExpenseDebt_1_Q2_USD":2918000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.127,"AdditionalPaidInCapital_0_Q2_USD":991574000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":175656000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":193000.0,"LinesOfCreditCurrent_0_Q2_USD":19056000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":20000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"ReceivablesNetCurrent_0_Q2_USD":3997000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7149000.0,"NetIncomeLoss_2_Q2_USD":-76206000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":10000000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_2_Q2_USD":43000.0,"AmortizationOfFinancingCosts_1_Q2_USD":341000.0,"CommonStockSharesOutstanding_0_Q2_shares":176429000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":92848000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":6365000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":568000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-817000.0,"CommonStockSharesAuthorized_0_Q2_shares":450000000.0,"OperatingIncomeLoss_2_Q2_USD":-79488000.0,"OperatingIncomeLoss_1_Q2_USD":-38510000.0,"NotesPayableCurrent_0_Q2_USD":29780000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":15935000.0,"InventoryNet_0_Q2_USD":5233000.0,"IncreaseDecreaseInInterestPayableNet_2_Q2_USD":2902000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":214706000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6034000.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":14817000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2188000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.48,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.24,"FinanceLeaseLiabilityCurrent_0_Q2_USD":1096000.0,"StockholdersEquity_0_Q2_USD":76507000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":15929000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":2871000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":7694000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-916834000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":59933000.0,"AmortizationOfFinancingCosts_2_Q2_USD":681000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-1405000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]